Pharmaceuticals & Bulk Drugs Regulations, DPCO & API Policy Updates
Daily notifications on Drugs & Cosmetics Act amendments, NPPA drug price control orders (DPCO), Bulk Drug Parks, and API PLI schemes.
Pharmaceuticals & Bulk Drugs Regulatory Landscape & Compliance Overview
Official IntelligencePolicyIndex indexes real-time gazette notifications, policy orders, tariff determinations, and compliance circulars issued across the Pharmaceuticals & Bulk Drugs sector. Regulatory intelligence is aggregated across central ministries, state regulatory commissions, and statutory authorities.
Statutory Directives
Official Extraordinary Gazettes, S.O. & G.S.R. orders, and executive notifications.
Compliance Mandates
Sector-specific regulatory obligations, licensing norms, and statutory filing guidelines.
Other Verticals in Healthcare, Pharmaceuticals & Life Sciences
Looking for Weekly Policy & Regulatory Briefings?
Access curated sector roundups, executive summaries, and downloadable PDF intelligence reports.
Latest Pharmaceuticals & Bulk Drugs News & Analysis
Health Ministry Moves Four Neurological Drugs to Schedule H1 List
The Health Ministry has issued draft rules adding Flupentixol, Zopiclone, Gabapentin, and Carisoprodol to Schedule H1 of the Drugs Rules, 19...
Official Pharmaceuticals & Bulk Drugs Gazettes & Notifications
Frequently Asked Questions on Pharmaceuticals & Bulk Drugs Regulations
What is the function of NPPA in drug pricing?
The National Pharmaceutical Pricing Authority (NPPA) fixes and revises prices of controlled bulk drugs and formulations under the DPCO to ensure drug affordability.